↓ Skip to main content

A clinical trial for the safety and immunogenicity of a DNA-based immunotherapy in men with biochemically (PSA) relapsed prostate cancer.

Overview of attention for article published in Journal of Clinical Oncology, February 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A clinical trial for the safety and immunogenicity of a DNA-based immunotherapy in men with biochemically (PSA) relapsed prostate cancer.
Published in
Journal of Clinical Oncology, February 2017
DOI 10.1200/jco.2017.35.6_suppl.80
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Librarian 1 13%
Other 1 13%
Lecturer 1 13%
Student > Doctoral Student 1 13%
Professor > Associate Professor 1 13%
Other 0 0%
Unknown 3 38%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 2 25%
Nursing and Health Professions 1 13%
Unknown 5 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2020.
All research outputs
#10,410,715
of 30,202,275 outputs
Outputs from Journal of Clinical Oncology
#17,753
of 27,924 outputs
Outputs of similar age
#133,172
of 330,261 outputs
Outputs of similar age from Journal of Clinical Oncology
#182
of 312 outputs
Altmetric has tracked 30,202,275 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 27,924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.5. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,261 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 312 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.